Obesity Clinical Trial
— QFSOfficial title:
The Quebec Family Study: an Observational Study Aimed at Investigating the Role of Genetic Factors in Physical Fitness, Obesity and Risk Factors for Common Diseases and Health-related Behaviours
Verified date | November 2017 |
Source | Laval University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The Quebec Family Study (QFS) is an observational study that was planned to investigate the role of genetic factors in physical fitness, body composition, risk factors for common disease and health-related behaviour.
Status | Completed |
Enrollment | 951 |
Est. completion date | September 5, 2002 |
Est. primary completion date | September 5, 2002 |
Accepts healthy volunteers | |
Gender | All |
Age group | 10 Years and older |
Eligibility |
Inclusion Criteria: - Age over 10 years Exclusion Criteria: |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Louis Pérusse | Canadian Institutes of Health Research (CIHR) |
Chaput JP, Pérusse L, Després JP, Tremblay A, Bouchard C. Findings from the Quebec Family Study on the Etiology of Obesity: Genetics and Environmental Highlights. Curr Obes Rep. 2014 Jan 4;3:54-66. doi: 10.1007/s13679-013-0086-3. eCollection 2014. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Body composition | Body composition as assessed by underwater weighing | Through study completion, an average of 24 years | |
Primary | Body mass index (kg/m^2) | Body mass index assessed from height and weight | Through study completion, an average of 24 years | |
Primary | Abdominal fat | Abdominal fat as assessed by commuted tomography | Through study completion, an average of 24 years | |
Primary | Waist and hip circumferences (cm) | Waist and hip circumferences (cm) | Through study completion, an average of 24 years | |
Secondary | Caloric intake | Total caloric intake and macronutrient intake using a 3-day dietary record | Through study completion, an average of 24 years | |
Secondary | Eating behaviour | Eating behaviour assessed using the Three-Factor Eating questionnaire | Through study completion, an average of 24 years | |
Secondary | Energy expenditure | Oxygen consumption at rest and during exercise | Through study completion, an average of 24 years | |
Secondary | Physical activity level | Physical activity level assessed by questionnaire | Through study completion, an average of 24 years | |
Secondary | Blood pressure (mm Hg) | Systolic and diastolic blood pressure | Through study completion, an average of 24 years | |
Secondary | Plasma lipid levels (mmol/L) | Fasting levels of triglycerides, LDL-cholesterol and HDL-cholesterol in mmo/L | Through study completion, an average of 24 years | |
Secondary | Glucose levels (mmol/L) | Plasma glucose levels in a fasting state and following an oral glucose tolerance test, inflammatory markers. Plasma glucose levels in a fasting state and during an oral glucose tolerance test |
Through study completion, an average of 24 years | |
Secondary | Insulin levels (pmol/L) | Plasma insulin levels in a fasting state and following an oral glucose tolerance test. | Through study completion, an average of 24 years | |
Secondary | C-reactive protein (CRP in mg/ml) | C-reactive protein (CRP in mg/ml) | Through study completion, an average of 24 years | |
Secondary | Adiponectin levels (in micrograms/ml) | Adiponectin levels (in micrograms/ml) | Through study completion, an average of 24 years | |
Secondary | Interleukin-6 (IL6) and tumor necrosis factor-alpha (TNF-alpha) in pg/ml | Interleukin-6 (IL6) and tumor necrosis factor-alpha (TNF-alpha) in pg/ml | Through study completion, an average of 24 years | |
Secondary | Smoking habits (nb of cigarettes per day) | Smoking habits (nb of cigarettes per day) | Through study completion, an average of 24 years | |
Secondary | Sleeping (hours/day) | Sleeping (hours/day) | Through study completion, an average of 24 years | |
Secondary | Alcohol consumption | Alcohol consumption (nb of drinks per week) | Through study completion, an average of 24 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |